RNA repair for haemophilia A

Abstract excerpt

The mainstay of gene transfer studies is the use of wild-type cDNAs to effect phenotypic correction of diseases. However, this strategy is not feasible for genetic diseases caused either by mutations of large genes or by dominant-negative mutations, or where the regulation of the gene is critical. In this review, we will discuss a novel RNA reprogramming strategy - spliceosome-mediated RNA trans-splicing - where...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hemophilia Treatment and Research
• Share to Neurogenetic and Muscular Disorders Research
• Share to RNA modifications and cancer